Other Names for this Disease
- 9q31.1q31.3 microdeletion syndrome
- Eosinophilic glassy cell hepatoma
- Eosinophilic hepatocellular carcinoma with lamellar fibrosis
- Fibrolamellar hepatocellular carcinoma
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
Fibrolamellar carcinoma (FLC) is a rare form of liver cancer which is generally diagnosed in adolescents and young adults (before age 40). Many people with early FLC have no signs or symptoms of the condition. When present, symptoms are often nonspecific (i.e. abdominal pain, weight loss, malaise) and blamed on other, more common conditions. The exact underlying cause of FLC is poorly understood. Unlike other forms of liver cancer, FLC typically occurs in the absence of underlying liver inflammation or scarring; thus, specific risk factors for this condition remain unidentified. FLC is typically treated with surgical resection.
Last updated: 4/23/2015
- Michael A Choti, MD, MBA, FACS. Fibrolamellar Carcinoma. Medscape Reference. August 2015; http://emedicine.medscape.com/article/278354-overview.
- Lim II, Farber BA, LaQuaglia MP. Advances in fibrolamellar hepatocellular carcinoma: a review. Eur J Pediatr Surg. December 2014; 24(6):461-466.
- Arief Suriawinata, MD. Pathology of malignant liver tumors. UpToDate. November 2014; Accessed 4/22/2015.
On this page
- Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
- Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.
- PubMed is a searchable database of medical literature and lists journal articles that discuss Fibrolamellar carcinoma. Click on the link to view a sample search on this topic.